The Eye in Bone Marrow Transplantation

Coskuncan, N M; Jabs, Douglas A.; Dunn, James P.; Haller, Julia A.; Green, W R; Vogelsang, Georgia B.; Santos, George W.

doi:10.1001/archopht.1994.01090150102031

Cited by 218 publications

(89 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…2 However, a retrospective study suggested that the incidence of CMV retinitis in childhood BMT recipients is extremely low. 3 The reason for this low incidence of CMV retinitis in BMT recipients is unknown.…”

Section: Discussionmentioning

confidence: 99%

CMV retinitis after cessation of ganciclovir therapy for CMV antigenemia in an unrelated BMT recipient

Suzuki

Kudoh

Mizue

et al. 1998

Bone Marrow Transplant

View full text Add to dashboard Cite

Summary:An 11-year-old boy with severe aplastic anemia underwent unrelated BMT following TBI, antithymocyte globulin and CY. On day +23, CMV antigenemia was detected which resolved with ganciclovir. Eight days after discontinuing ganciclovir, he complained of impaired visual acuity. Ophthalmologic findings and a positive PCR study using anterior chamber fluid from the right eye confirmed the presumptive diagnosis of CMV retinitis, although CMV antigenemia and PCR studies using PBMC were then negative. He was successfully re-treated with ganciclovir. CMV retinitis should be considered even when CMV antigenemia is not present or PCR using PBMC is negative.

show abstract

Section: Discussionmentioning

confidence: 99%

CMV retinitis after cessation of ganciclovir therapy for CMV antigenemia in an unrelated BMT recipient

Suzuki

Kudoh

Mizue

et al. 1998

Bone Marrow Transplant

View full text Add to dashboard Cite

show abstract

“…In the acute phase, there are four stages of severity: hyperemia, chemosis, pseudomembranous conjunctivitis with complete loss of conjunctival epithelium and finally, compromise of the www.intechopen.com corneal epithelium. (Jabs et al, 1989;Sanders, 2002;Uchino et al, 2006) Its presence is related to vital prognosis with a mortality rate of 90% for stages 2 through 4 (Coskuncan 1994, Ohkoshi 1992. Fig.…”

Section: Orbit and Eyelidsmentioning

confidence: 99%

Ophthalmological Manifestations in Acute Lymphoblastic Leukemia

Mateo¹,

Ascaso²,

Núñez³

et al. 2011

Novel Aspects in Acute Lymphoblastic Leukemia

View full text Add to dashboard Cite

“…The most commonly reported posterior segment complications are either intraretinal or vitreous haemorrhages according to the literatures. 2 We present two cases of exudative bullous retinal detachment (RD) in two patients after PBSCT who develop severe and potentially vision-threatening complications. Since our two cases died shortly after the diagnosis, bullous RD may be a poor prognostic factor for survival after PBSCT.…”

Section: Sir Exudative Bullous Retinal Detachment After Peripheral Bmentioning

confidence: 99%

Exudative bullous retinal detachment after peripheral blood stem cell transplantation

Peng

Chen

Lin

et al. 2004

Eye

View full text Add to dashboard Cite

The Eye in Bone Marrow Transplantation

Cited by 218 publications

References 29 publications

CMV retinitis after cessation of ganciclovir therapy for CMV antigenemia in an unrelated BMT recipient

CMV retinitis after cessation of ganciclovir therapy for CMV antigenemia in an unrelated BMT recipient

Ophthalmological Manifestations in Acute Lymphoblastic Leukemia

Exudative bullous retinal detachment after peripheral blood stem cell transplantation

Contact Info

Product

Resources

About